IPOPLUS

648.2

+8.85 +1.38%

17 Jun 2026

NSE Listed · Pharmaceuticals

Aarti Pharmalabs Limited (AARTIPHARM)

Volume: 6,769Avg Vol 1W: 61,839Avg Vol 1M: 98,31052W Range:585971
₹648.2 1.38%
Key Ratios
Updated 3h ago
Market Cap₹5,792 Cr
Current Price₹648.2
Previous Close₹639.35
High / Low (52w)₹971 / ₹585
Volume6,769
Avg Vol (1W)61,839
Avg Vol (1M)98,310
Stock P/E
Book Value₹234.35
Dividend Yield0.55%
ROE8.22%
ROA5.36%
Revenue (TTM)
Revenue Growth14.17%
Profit Margin10.25%
Total Debt₹104 Cr
Shares Outstanding9 Cr
Face Value₹5
EPS (TTM)₹6.74
P/B2.73
Debt / Equity0.36
50 DMA₹668.86
200 DMA₹699.81
Day change+1.38%
Price Chart
648.2 24.63% · 1Y
88058914.6L
2025-10-21
2026-06-16

20-day avg volume: 97K shares

Pros
  • Company is almost debt-free.
  • Revenue grew 14% YoY.
  • Net profit is growing year over year.
Quarterly Results
MetricMar 2026Dec 2025Sept 2025Jun 2025Mar 2025Dec 2024Sept 2024Jun 2024Mar 2024Dec 2023Sept 2023Jun 2023Mar 2023Dec 2022Sept 2022Jun 2022Mar 2022
Revenue₹583 Cr₹432 Cr₹418 Cr₹386 Cr₹564 Cr₹538 Cr₹458 Cr₹555 Cr₹506 Cr₹449 Cr₹440 Cr₹458 Cr₹485 Cr₹472 Cr₹531 Cr₹457 Cr₹460 Cr
EBITDA₹93 Cr₹73 Cr₹50 Cr₹74 Cr₹121 Cr₹111 Cr₹77 Cr₹79 Cr₹100 Cr₹78 Cr₹71 Cr₹68 Cr₹65 Cr₹70 Cr₹74 Cr₹72 Cr₹64 Cr
Net Profit₹61 Cr₹48 Cr₹28 Cr₹50 Cr₹88 Cr₹74 Cr₹55 Cr₹55 Cr₹65 Cr₹53 Cr₹52 Cr₹47 Cr₹43 Cr₹48 Cr₹51 Cr₹52 Cr₹49 Cr
EPS6.745.293.085.469.748.166.026.127.25.825.725.24.735.265.645.725.39
Profit & Loss (Annual)
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Revenue₹2,125 Cr₹1,858 Cr₹1,948 Cr₹1,202 Cr₹0 Cr₹0 Cr
EBITDA₹388 Cr₹318 Cr₹282 Cr₹167 Cr₹0 Cr₹0 Cr
Net Profit₹272 Cr₹217 Cr₹193 Cr₹122 Cr₹0 Cr₹0 Cr
EPS30.0423.9321.3513.49-0.18-0.75
Balance Sheet
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021Mar 2020
Total Assets₹2,906 Cr₹2,582 Cr₹2,244 Cr₹2,040 Cr₹0 Cr₹0 Cr
Total Liabilities₹917 Cr₹825 Cr₹686 Cr₹653 Cr₹0 Cr₹0 Cr
Equity₹1,990 Cr₹1,757 Cr₹1,558 Cr₹1,386 Cr₹0 Cr₹0 Cr
Total Debt₹104 Cr₹0 Cr₹0 Cr₹1 Cr₹0 Cr₹0 Cr
Cash Flow
MetricMar 2025Mar 2024Mar 2023Mar 2022Mar 2021
Operating₹396 Cr₹273 Cr₹312 Cr₹-23 Cr₹0 Cr
Investing₹-414 Cr₹-215 Cr₹-158 Cr₹-139 Cr₹0 Cr
Financing₹65 Cr₹10 Cr₹-163 Cr₹260 Cr₹0 Cr
Free Cash Flow₹396 Cr₹273 Cr₹313 Cr₹-23 Cr₹0 Cr
Shareholding
Promoter 43.08% Institutions 15.8% Public 41.11%

Prices are delayed/indicative; pros & cons are AI generated. Informational only — not investment advice. ← Back to search